Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study by Fernández, Ana, Salgado, Mercedes, García, Adelaida, Buxò, Elvira, Vera, Ruth, Adeva, Jorge, Jiménez-Fonseca, Paula, Quintero, Guillermo, Llorca, Cristina, Cañabate, Mamen, López, Luis Jesús, Muñoz, Andrés, Ramírez, Patricia, González, Paula, López, Carlos, Reboredo, Margarita, Gallardo, Elena, Sanchez-Cánovas, Manuel, Gallego, Javier, Guillén, Carmen, Ruiz-Miravet, Nuria, Navarro-Pérez, Víctor, De la Cámara, Juan, Alés-Díaz, Inmaculada, Pazo-Cid, Roberto Antonio, Carmona-Bayonas, Alberto

Get full text

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/... by Colombo, N., Gadducci, A., Sehouli, J., Rulli, E., Mäenpää, J., Sessa, C., Montes, A., Ottevanger, N. B., Berger, R., Vergote, I., D’Incalci, M., Churruca Galaz, C., Chekerov, R., Nyvang, G. B., Riniker, S., Herbertson, R., Fossati, R., Barretina-Ginesta, M. P., Deryal, M., Mirza, M. R., Biagioli, E., Iglesias, M., Funari, G., Romeo, M., Tasca, G., Pardo, B., Tognon, G., Rubio-Pérez, M. J., DeCensi, A., De Giorgi, U., Zola, P., Benedetti Panici, P., Aglietta, M., Arcangeli, V., Zamagni, C., Bologna, A., Westermann, A., Heinzelmann-Schwarz, V., Tsibulak, I., Wimberger, P., Poveda, A.

Get full text